Agilent Technologies Stock News

The antibody is called immunoglobulin which is produced by plasma cells to certain antigens. The widespread of Covid-19 has driven the Global Research antibody Market. The detection & diagnosis of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgM/IgG

Janney Montgomery Scott LLC raised its stake in Agilent Technologies, Inc. (NYSE:A) by 1.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,617 shares of the medical research companys stock after acquiring an additional 231 shares during the period. Janney Montgomery Scott LLCs []

Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen sold 123,459 shares of the firms stock in a transaction on Monday, December 20th. The shares were sold at an average price of $148.82, for a total value of $18,373,168.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be []

DUBLIN--(BUSINESS WIRE)--The "Bioinformatics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global bioinformatics market is expected to grow from $9.38 billion in 2020 to $10.57 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%. The market is expected to reach $18.46 billion in 2025 at a CAGR of 15%. Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and

The North America Anatomic Pathology Market is expected to reach US$ 13,970.95 million by 2028 from US$ 8,870.41 million in 2021; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028. The anatomic pathology is a significant

Signaturefd LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,751 shares of the medical research companys stock after purchasing an additional 252 shares during the quarter. Signaturefd LLCs holdings []

The Biomarker Technologies Market research report provides broad, subjective bits of knowledge on the potential and specialty portions or regions displaying good growth. The Biomarker Technologies Market research report comprehensively investigates the current and developing business sector patterns and openings

This Infertility Testing And Treatment market report analyzed the market conditions of key region of the world including product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. The report introduced the new project SWOT analysis,

Kingfisher Capital LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 29,836 shares of the medical research companys stock after purchasing an additional 793 shares during the period. Agilent Technologies comprises 1.2% of Kingfisher Capital LLCs holdings, []

DUBLIN--(BUSINESS WIRE)--The "Cannabis Testing Services Market Research Report by Type, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com''s offering. The Global Cannabis Testing Services Market size was estimated at USD 318.46 million in 2020, is expected to reach USD 373.58 million in 2021, and projected to grow at a CAGR of 17.64% reaching USD 844.28 million by 2026. Competitive Strategic Window The Competitive Stra

Latest Business Market Insights added report on North America Synthetic Biology Market research study by Market Digits offers detailed product outlook and elaborates market review till 2027. The market Study is segmented by key regions that is accelerating the marketization.

DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the global oligonucleotide synthesis market to grow at a CAGR of 12.7% during the forecast period (2021-2026). Companies Mentioned Agilent Technologies Inc. Biolegio B.V

Nicoya''s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) Nicoya Lifesciences, a global leader in digital proteomi

Ballentine Partners LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,722 shares of the medical research companys stock after buying an additional 94 shares during the quarter. []

Marshall Financial Group LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 4.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,106 shares of the medical research companys stock after selling 104 shares during the quarter. Marshall Financial Group LLCs holdings in Agilent Technologies were worth []